EchoGo® Heart Failure vs Imbio RV/LV Software
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A, EchoGo® Heart Failure, is designed for diagnosing HFpEF by analyzing echocardiograms, providing rapid insights for clinical decisions. In contrast, Tool B, Imbio RV/LV Software, focuses on measuring right and left ventricular diameters from CTPA scans to aid in risk stratification for pulmonary conditions. While both utilize AI for cardiac imaging analysis, they operate on different imaging modalities and address distinct clinical questions.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
EchoGou00ae Heart Failure (Tool A) is designed to analyze routine echocardiograms to detect HFpEF. Imbio RV/LV Software (Tool B) automatically measures right and left ventricular diameters from CTPA scans to aid in risk stratification for pulmonary conditions.
EchoGou00ae Heart Failure (Tool A) analyzes routine echocardiogram video clips. Imbio RV/LV Software (Tool B) analyzes CTPA scans.
EchoGou00ae Heart Failure (Tool A) is reimbursable via CPT code 0932T for outpatient analysis, with a national Medicare average of $316 per analysis. Imbio RV/LV Software (Tool B) is subscription-based, with pricing based on the number of analyses or installations.
EchoGou00ae Heart Failure (Tool A) is clinically validated with 90% sensitivity and 86% specificity for HFpEF detection. The provided information for Imbio RV/LV Software (Tool B) does not detail specific clinical performance metrics like sensitivity or specificity.
EchoGou00ae Heart Failure (Tool A) delivers insights within 20 minutes and generates automated structured reports. Imbio RV/LV Software (Tool B) calculates and reports RV/LV ratios, provides annotated images showing ventricular measurements, and generates summary PDF reports.